Search
Enliven Therapeutics Inc
ELVNAdd to Watchlist
50.505USD
-0.245-0.48%
Market hours （ET）Quotes delayed by 15 min
3.08BMarket Cap
LossP/E TTM
Enliven Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.83
3.24%
Analyst Rating
BUY
2026-06-30
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its current assets were 474.88M, with a year-on-year change of 49.27.
What are the total assets of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its total assets of Enliven Therapeutics Inc were 476.17M, with a year-on-year change of 46.17.
What are the total liabilities of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its total liabilities of Enliven Therapeutics Inc were 16.57M, with a year-on-year change of 4.10.
What is the total equity of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its total equity of Enliven Therapeutics Inc was 459.60M, with a year-on-year change of 48.33.
What is the net investment of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its net investment of Enliven Therapeutics Inc was -173.84M, with a year-on-year change of -382.93.
What is the net financing of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its net financing of Enliven Therapeutics Inc was 218.87M, with a year-on-year change of 64.36.
What is the Earnings Per Share (EPS) of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.83, with a year-on-year change of 3.24.
What is the Return on Equity (ROE) of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -26.95, with a year-on-year change of 15.87.
What is the Return on Assets (ROA) of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -25.86, with a year-on-year change of 13.20.
What is the operating profit of Enliven Therapeutics Inc?
According to Enliven Therapeutics Inc's FY2025 earnings report, its operating profit was -119.66M, with a year-on-year change of -14.45.